B 417 (Mephobarbital 50 mg)
Pill with imprint B 417 is White, Round and has been identified as Mephobarbital 50 mg. It is supplied by Breckenridge Pharmaceutical Inc.
Mephobarbital is used in the treatment of seizure prevention; epilepsy; sedation and belongs to the drug classes barbiturate anticonvulsants, barbiturates. There is positive evidence of human fetal risk during pregnancy. Mephobarbital 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for B 417
Mephobarbital
- Imprint
- B 417
- Strength
- 50 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Barbiturate anticonvulsants, Barbiturates
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Breckenridge Pharmaceutical Inc
- National Drug Code (NDC)
- 51991-0417 (Discontinued)
More about mephobarbital
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- 4 Reviews
- Drug class: barbiturate anticonvulsants
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.